电邮这篇文章 Experience of using the 1,5% Tetranyl U cream in patients with tinea corporis and tinea cruris
- 作者: Maximov I.1, Petukhova E.1
-
隶属关系:
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- 期: 卷 25, 编号 2 (2022)
- 页面: 151-158
- 栏目: DERMATOLOGY
- URL: https://journals.rcsi.science/1560-9588/article/view/109086
- DOI: https://doi.org/10.17816/dv109086
- ID: 109086
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
BACKGROUND: Over the past ten years, there has been a persistent increase in the resistance of dermatophytes to antifungal drugs. The development of new drugs and the evaluation of the effectiveness of medicines is a priority in mycology.
AIMS: Evaluation of the effectiveness and safety of using the cream containing Tetranyl U and 10% urea in the treatment of tinea corporis and tinea cruris.
MATERIALS AND METHODS: The study included 30 patients with a laboratory-confirmed diagnosis of tinea corporis and tinea cruris of mild to moderate severity. Patients were recommended to use the cream which was applied to the lesions 2 times a day for 3 weeks. The evaluation of the severity the course of mycosis and the effectiveness of the cream was carried out by calculating a 4-point PGA (Physician Global Assessment) before treatment and after 3 weeks of using the cream.
RESULTS: According to the results of the study, the clinical efficacy was 81.8%. Mycological response (negative direct microscopy + mycological culture) was achieved in 82.8% of patients.
CONCLUSION: The cream containing Tetranyl U showed good efficacy and tolerability in the treatment of tinea corporis and tinea cruris, which is confirmed by the results of clinical and microbiological studies.
作者简介
Ivan Maximov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
编辑信件的主要联系方式.
Email: maximov.is@mail.ru
ORCID iD: 0000-0003-2850-2910
Assistant
俄罗斯联邦, MoscowEugenia Petukhova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: petuxova0304@gmail.com
ORCID iD: 0000-0002-9396-4874
Student
俄罗斯联邦, Moscow参考
- Tirado-Sánchez A, González GM, Bonifaz A. Endemic mycoses: epidemiology and diagnostic strategies. Expert Rev Anti Infect Ther. 2020;18(11):1105–1117. doi: 10.1080/14787210.2020.1792774
- Sacheli R, Hayette MP. Antifungal resistance in dermatophytes: genetic considerations, clinical presentations and alternative therapies. J Fungi (Basel). 2021;7(11):983. doi: 10.3390/jof7110983
- Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51(Suppl 4):2–15. doi: 10.1111/j.1439-0507.2008.01606.x
- Resources and activities of medical organizations of dermatovenerological profile. The incidence of sexually transmitted infections, infectious skin diseases and skin diseases for 2017–2018. (Statistical materials). Moscow; 2019. 208 p. (In Russ).
- Monod M. Antifungal resistance in dermatophytes: Emerging problem and challenge for the medical community. J Mycol Med. 2019;29(4):283–284. doi: 10.1016/j.mycmed.2019.100913
- Nenoff P, Verma SB, Vasani R, et al. The current Indian epidemic of superficial dermatophytosis due to Trichophyton mentagrophytes ― a molecular study. Mycoses. 2019;62(4):336–356. doi: 10.1111/myc.12878
- Shi D, Zhao Y, Yan H, et al. Antifungal effects of undecylenic acid on the biofilm formation of Candida albicans. Int J Clin Pharmacol Ther. 2016;54(5):343–353. doi: 10.5414/CP202460
- Mionić Ebersold M, Petrović M, Fong WK, et al. Hexosomes with Undecylenic acid efficient against Candida albicans. Nanomaterials (Basel). 2018;8(2):91. doi: 10.3390/nano8020091
- Smith EB, Powell RP, Graham JL, Ulrich JA. Topical undecylenic acid in tinea pedis: a new look. Int J Dermatol. 1977;16(1):52–56. doi: 10.1111/j.1365-4362.1977.tb00741.x
- Karpova OA. Mycostop ― an integrated approach to the treatment and prevention of onychomycosis. Advances in Medical Mycology. 2019;20:136–140. (In Russ).
- Clinical recommendations of the Russian Society of Dermatovenerologists and Cosmetologists “Mycosis of the scalp, trunk, hands and feet”. Moscow; 2020. 53 р. (In Russ).
补充文件
